Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06593418 · ClinicalTrials.gov registry record · NA

Cardiac Radioablation for VT

A NA study of Myocardial Infarction and Ventricular Tachycardia, sponsored by Corewell Health East.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT06593418: Recruiting NA study of Myocardial Infarction and Ventricular Tachycardia, sponsored by Corewell Health East.

NCT06593418 is a NA study of Myocardial Infarction and Ventricular Tachycardia that is actively recruiting participants, run by Corewell Health East. The registered enrollment target is 24 participants, below the 4,681-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06593418, a NA study of Myocardial Infarction and Ventricular Tachycardia, is actively recruiting participants, sponsored by Corewell Health East.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The goal of this interventional study is to determine the minimum dose necessary for successful cardiac radioablation of refractory ventricular tachycardia (VT) and to study the utility of target volume definition using Delayed Enhancement Cardiac MRI (DE-CMR) .

Primary Outcome

Change in the number of episodes of VT over the 56 days before treatment versus over a consecutive 56 days post treatment (following the 6 week post-treatment blanking period). A negative number represents a reduction in episodes after treatment (improved function) and a positive number represents an increase in episodes after treatment (worsened function).

Interventions

  • RADIATION Stereotactic Body Radiation Therapy (SBRT)

Study Locations (1)

Michigan

  • Corewell Health William Beaumont University Hospital - Royal Oak

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2025-09
Est. Completion 2026-09
Phase NA
Corewell Health East

106 total trials

What NCT06593418 shows while recruiting

NCT06593418 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 4,681-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which Stereotactic Body Radiation Therapy (SBRT) is the first listed.

NCT06593418 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06593418 about?

NCT06593418 is a clinical study titled "Cardiac Radioablation for VT". The goal of this interventional study is to determine the minimum dose necessary for successful cardiac radioablation of refractory ventricular tachycardia (VT) and to study the utility of target volume definition using Delayed Enhancement Cardiac MRI (DE-CMR) .

What is the current status of trial NCT06593418?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-09. Estimated completion is 2026-09.

What conditions does trial NCT06593418 study?

This clinical trial studies the following conditions: Myocardial Infarction, Ventricular Tachycardia.

What interventions are being tested in trial NCT06593418?

The interventions under investigation include: Stereotactic Body Radiation Therapy (SBRT) (RADIATION).

Who is sponsoring clinical trial NCT06593418?

This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06593418 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06593418's enrollment target sits among peer trials

24 62nd of 64 higher than 3 of 64 other Myocardial Infarction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06593418, the US trial registry maintained by the National Library of Medicine. NCT06593418 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.